Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Lung Cancer
Lung Cancer News & Features
Bill Aims to Limit Nicotine in E-Cigarette Products
Bill would restrict nicotine content to a maximum of 20 mg/mL.
Durvalumab Still Beneficial Despite Association With Radiation Pneumonitis
A substudy of the PACIFIC trial sought to determine if low-grade pneumonitis associated with durvalumab should deter its use in patients with NSCLC.
Neurologic Deficits Shorten Overall Survival in NSCLC With Brain Metastases at Diagnosis
An analysis of patients with NSCLC and brain metastases at diagnosis found intracranial pressure and seizures had no impact, but other neurologic defects had an effect on overall survival.
Nurse-Led Program Conducts Follow-up After Resection for Early-Stage Lung Cancer
A program in which a nurse specialist coordinates CT imaging and follow-up for patients who underwent surgical resection for early-stage lung cancer was described in a presentation at the 2019 World Conference on Lung Cancer.
Lung Cancer Clinical Trials
Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer
Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer
Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)
Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)
Want to read more?
Please login or register first to view this content.
Next post in Lung Cancer
